News | SCAI | May 17, 2020

Cindy Grines Becomes SCAI President

Cindy Grines Becomes SCAI President in 2020. #SCAI2020

May 17, 2020 — Cindy Grines, M.D., MSCAI, a world-renowned physician credited for pioneering percutaneous coronary intervention (PCI) for heart attacks, has assumed the office of president of the Society for Cardiovascular Angiography and Interventions (SCAI). Grines’ tenure as president officially begans Saturday, May 16, during the SCAI 2020 Scientific Sessions Virtual Conference. Grines is the third female interventionalist to lead the society.

“Dr. Grines is a luminary in the field of interventional cardiology, and we are thrilled she will serve as SCAI president for the upcoming year,” said Francesca Dea, CAE, chief executive officer of SCAI. “During this tumultuous time in global history it will be invaluable to have Dr. Grines’ vast expertise and visionary mindset help steer a course for the future of interventional cardiology and how cath lab teams adapt their patient care. Her contributions and experience will ensure that SCAI advances in a way to best serve our members and their patients.”

A longtime, devoted member of SCAI, Grines has been an inaugural supporter of SCAI Women in Innovations (SCAI-WIN). SCAI-WIN is a worldwide effort devoted to improving the overall approach to the medical treatment of women with cardiovascular disease, as well as increasing the quality and scope of professional opportunities offered to female interventional cardiologists.

Currently serving as the chief scientific officer of the Northside Cardiovascular Institute in Atlanta, Grines has a long history of research, publications, and clinical trial design with more than 500 publications and numerous book chapters and review chapters. Grines serves on the editorial boards of several major journals both nationally and internationally and has co-edited several medical handbooks. Grines received her doctor of medicine from Ohio State University College of Medicine and completed her cardiology fellowship at the University of Michigan.

During her presidency, Grines plans to focus on diversity and inclusiveness across the Society, enhanced membership engagement, proactive digital education and access, continued engagement with our sister organizations, and to further increase SCAI’s visibility globally through educational and case-reviewed programs both regionally and internationally.

Other incoming officers of SCAI’s 2020-21 Executive Committee include:
   • Timothy D. Henry, M.D., MSCAI, as president-elect;
   • Sunil V. Rao, M.D., FSCAI, as vice president; 
   • George D. Dangas, M.D., MSCAI, as secretary; 
   • Peter L. Duffy, M.D., FSCAI, as treasurer; 
   • Arnold H. Seto, M.D., FSCAI, as associate treasurer; and 
   • Ehtisham Mahmud, M.D., FSCAI, as immediate past-president.

For more information: www.scai.org
 

Related Content

Medtronic is recalling its Pipeline Flex Embolization Device and Pipeline Flex Embolization Device with Shield Technology, which are transcatheter devices used to seal brain aneurysms. The company said there is a risk of the delivery system’s wire and tubes fracturing and breaking off when the system is being used to place, retrieve, or move the stent inside a patient.
News | Cath Lab | September 21, 2021
September 21, 2021 — Medtronic is recalling its Pipeline Flex Embolization Device and Pipeline Flex Embolization Devi
Feature | Cath Lab | September 14, 2021 | By Aaron Detate and Lars Thording
In the electrophysiology (EP) lab, hundreds
An example of the Medis QCA angiography imaging derived fractional flow reserve (FFR) assessment. This technology removes the need for pressure wires and adenosine used in traditional FFR assessments of the coronary arteries.

An example of the Medis QCA angiography imaging derived fractional flow reserve (FFR) assessment. This technology removes the need for pressure wires and adenosine used in traditional FFR assessments of the coronary arteries.

News | Cath Lab | July 22, 2021
July 22, 2021 — Medis Medical Imaging is partnering with CORRIB Core Lab and Sinomed in randomized clinical trial of
ast End Medical announced it received U.S. Food and Drug Administration (FDA) clearance for the company's SafeCross Transseptal Radiofrequency (RF) Puncture and Steerable Balloon Introducer System. The 3-in-1 system, which includes a steerable introducer sheath with an ultra-visible positioning balloon and radiofrequency (RF) puncture dilator, aims to provide a predictable and safe solution for electrophysiology (EP) and structural heart interventions requiring left atrial access.
News | Cath Lab | July 14, 2021
July 13, 2021 — East End Medical announced it received U.S.
There is a trend in interventional cardiology that is now being called “renalism,” where patients with poor renal function are being excluded from interventional procedures because they are automatically considered too high risk. However, some hospitals are also creating cardio-renal care teams so these patients can be cared for by a team of experts rather than interventional cardiologists going it alone. #SCAI21 #SCAI2021 Creating a card0-renal program.

There is a trend in interventional cardiology that is now being called “renalism,” where patients with poor renal function are being excluded from interventional procedures because they are automatically considered too high risk. However, some hospitals are also creating cardio-renal care teams so these patients can be cared for by a team of experts rather than interventional cardiologists going it alone.

Feature | Cath Lab | May 14, 2021 | By Dave Fornell, Editor
There is a trend in interventional cardiology that is now being called “renalism,” where patients with poor renal fun
Abbott recently announced its new interventional imaging platform powered by Ultreon 1.0 Software, has gained European CE marked. This first-of-its-kind imaging software merges optical coherence tomography (OCT) intravascular imaging with the power of artificial intelligence (AI) for enhanced visualization. The new Ultreon Software can automatically detect the severity of calcium-based blockages and measure vessel diameter to enhance the precision of physicians’ decision-making during coronary stenting proc

Abbott recently announced its new interventional imaging platform powered by Ultreon 1.0 Software, has gained European CE marked. This first-of-its-kind imaging software merges optical coherence tomography (OCT) intravascular imaging with the power of artificial intelligence (AI) for enhanced visualization. The new Ultreon Software can automatically detect the severity of calcium-based blockages and measure vessel diameter to enhance the precision of physicians’ decision-making during coronary stenting procedures.

News | Cath Lab | May 12, 2021
May 12, 2021 — Abbott recently announced its new interventional imaging platform powered by Ultreon 1.0 Software, has
SCAI 2021 late-breaking presentations included the data on the Medtronic Harmony transcatheter pulmonary valve, cutting radial access hemostasis time by 50 percent, improving cardiogenic shock survival to 71 percent, and data showing very high mortality in COVID patients who suffer a STEMI heart attack. #SCAI21 #SCAI2021

SCAI 2021 late-breaking presentations included the data on the Medtronic Harmony transcatheter pulmonary valve, cutting radial access hemostasis time by 50 percent, improving cardiogenic shock survival to 71 percent, and data showing very high mortality in COVID patients who suffer a STEMI.

Feature | Cath Lab | May 06, 2021 | By Dave Fornell, Editor
April 29, 2021 — Here is the list of late-breaking study presentations and links to articles about each of them from
Most Stable Ischemic Heart Disease Patients Did Not Meet ISCHEMIA Trial Enrollment Criteria, raising questions about its application in real-world practice. #SCAI2021 Getty Images

Getty Images

News | Cath Lab | May 03, 2021
May 3, 2021 – Results from a new study find a broad range of patients who typically undergo revascularization for sta
New study demonstrates depression, HIV, mental health, obesity, alcohol and drug abuse are risk factors on most common type of heart disease in young black patients. Photo by Dave Fornell
News | Cath Lab | April 29, 2021
April 29, 2021 – A retrospective analysis of risk factors for coronary artery disease (CAD) in young African American